CD44 and prostate cancer: Another in vitro study reveals that ALDH (high) CD44(+) cells exhibit a higher proliferative, clonogenic and metastatic capacity compared to ALDH(low) CD44(−) cells, suggesting that ALDH has higher tumorigenicity capacity in prostatic cancer [39].